Related Experiment Video

Updated: Jul 28, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.8K

Letter to the Editor-Recent advances in Lynch syndrome

Pål Møller1, Julian Sampson2, Mev Dominguez-Valentin3

  • 1Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. moller.pal@gmail.com.

Familial Cancer
|August 10, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.6K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Related Experiment Videos

Last Updated: Jul 28, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.8K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.6K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

The Tumor Microenvironment Score and Its Subsite-Specific Relevance in Colon Cancer.

The American journal of surgical pathology·2026

Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1.

Oncogene·2026

Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022.

Gut·2026

Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial.

The lancet. Gastroenterology & hepatology·2026

Tumor-Infiltrating Basophils Are Associated With Improved Prognosis in Colorectal Cancer.

Laboratory investigation; a journal of technical methods and pathology·2026

Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.

The Journal of pathology·2026

The identification of a PRKACA duplication at 19p13.12 in a female with PPNAD and thyroid carcinoma after a 20-year diagnostic journey.

Familial cancer·2026

The evolution of hereditary cancer genetic counselling: mainstreaming, service redesign and patient experience in Lynch syndrome.

Familial cancer·2026

Opportunities to improve detection of genetic predisposition for ovarian cancer applying the Tumor-First workflow.

Familial cancer·2026

Routes to colorectal cancer in Lynch syndrome: a decade of molecular and clinical insights converging on Schrödinger's cat.

Familial cancer·2026

Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain.

Familial cancer·2026

Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey.

Familial cancer·2026

Interpretable but Not Necessarily Meaningful: Language, Voice, and Clinical Inference in AI-Based Mental Health Prediction-A Commentary on Wang and Sambamoorthi (2026).

Journal of voice : official journal of the Voice Foundation·2026

European Practice Consensus on Office-Based Laryngology.

The Laryngoscope·2026

Correction: Lin et al. Prospects and Challenges of Lung Cancer Vaccines. Vaccines 2025, 13, 836.

Vaccines·2026

Confirmation of HLA-C*07:24:02 in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026

Latent profile analysis of eHealth literacy and its sociodemographic correlates: a cross-sectional study.

Frontiers in public health·2026

Correction: 'She lifted me up': kinship construction in human-AI resilient communication among Chinese users.

Frontiers in psychology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us